Philips set to acquire Vesper Medical
Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease
Vesper Medical will further expand Philips’ portfolio of diagnostic and therapeutic devices with an advanced venous stent portfolio for the treatment of deep venous disease
Scoliosis is a disorder of the spine, and its surgeries are generally done only in large hospitals in big cities.
Phase 1 study of quadrivalent flu vaccine (mRNA-1010) successfully boosted titers against all four strains in older and younger adults, even at lowest dose; no significant safety concerns were observed
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
The offline store launch will complement the E-commerce website in building a rich consumer shopping experience
The three doses of ZyCoV-D are to be administered 28 days apart. The vaccine was given emergency use authorisation (EUA) by the Indian drug regulator on August 20
The companies expect to manufacture over 80 million does of the Covid-19 vaccine in 2022
The company is moving towards complex and more differentiated products
The European Commission (EC) granted marketing authorisation for Celltrion’s regdanvimab following a positive opinion by the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) last week
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
Subscribe To Our Newsletter & Stay Updated